Watch ELVN. Know when insiders buy.
One email the day a filing lands. Free.
ELVN
Enliven Therapeutics, Inc.
41.49
−0.03 −0.07%
USD · Oct 26, 07:41 p.m. ET
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
33
FLAG · insiders 25, shorts 40
Insiders, 90 days
−$1.6M
net selling · 0 buys, 9 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $3BP/E —DIV YIELD —FCF YIELD -2.21%REV TTM —NET INCOME −$105.9MNET CASH —52W 15.14 – 61.15NEXT EARNINGS Nov 11 EST.SEC XBRL · TTM TO Invalid Date
Who holds it
None of the 15 tracked funds disclose ELVN in their latest 13F. The funds we follow.
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
No 13D or 13G filing on ELVN in the last two years from the filings we read (13G only for companies we track; the sweep began Sep 2026).
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.